{"id":360170,"date":"2023-06-19T09:58:11","date_gmt":"2023-06-19T07:58:11","guid":{"rendered":"https:\/\/medizinonline.com\/covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid\/"},"modified":"2023-06-19T13:37:43","modified_gmt":"2023-06-19T11:37:43","slug":"covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/covid-19-na-pratica-quotidiana-a-opcao-de-tratamento-com-paxlovid\/","title":{"rendered":"COVID-19 na pr\u00e1tica quotidiana: a op\u00e7\u00e3o de tratamento com PAXLOVID\u00ae"},"content":{"rendered":"\n<p><strong>Os medicamentos antivirais podem ser utilizados em doentes com COVID-19 com risco acrescido de progress\u00e3o grave da doen\u00e7a.<sup>1, 2<\/sup> O antiv\u00edrico PAXLOVID\u00ae (nirmatrelvir  [PF-07321332]  \/ ritonavir) \u00e9 o \u00fanico tratamento oral para a COVID-19 aprovado e recomendado na Su\u00ed\u00e7a.<sup>2-4<\/sup> O tratamento de cinco dias pode ser dispensado por todas as farm\u00e1cias, mediante receita m\u00e9dica, e diretamente pelos m\u00e9dicos que fazem a auto-dispensa, e deve ser utilizado o mais rapidamente poss\u00edvel ap\u00f3s um teste viral positivo para o SARS-CoV-2.<sup>1-3<\/sup><\/strong><\/p>\n\n<!--more-->\n\n<p>No webcast, a Dr.\u00aa Dominique Braun, m\u00e9dica s\u00e9nior com responsabilidade alargada na Cl\u00ednica de Doen\u00e7as Infecciosas e Higiene Hospitalar do Hospital Universit\u00e1rio de Zurique, apresenta a terapia antiviral para a COVID-19 na Su\u00ed\u00e7a, e a Prof.\u00aa Catia Marzolini, farmacologista das Universidades de Liverpool e Basileia e respons\u00e1vel cient\u00edfica da  <a href=\"https:\/\/www.covid19-druginteractions.org\/\" target=\"_blank\" rel=\"noopener\">Verificador de interac\u00e7\u00f5es medicamentosas com a COVID-19<\/a><sup>5<\/sup>A tabela seguinte mostra aquilo a que deve estar atento em termos de interac\u00e7\u00f5es medicamentosas com PAXLOVID\u00ae.  <\/p>\n\n<figure class=\"wp-block-embed is-type-video is-provider-vimeo wp-block-embed-vimeo wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"2023-03-16_Webinar_COVID_19_im_Praxisalltag__die_Behandlungsm\u00f6glichkeit_mit_PAXLOVID_JBe_2.3\" data-src=\"https:\/\/player.vimeo.com\/video\/822993573?dnt=1&amp;app_id=122963\" width=\"1160\" height=\"653\" frameborder=\"0\" allow=\"autoplay; fullscreen; picture-in-picture\" allowfullscreen src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe>\n<\/div><figcaption class=\"wp-element-caption\">webcast dr. braun &amp; prof. marzolini<\/figcaption><\/figure>\n\n<p><strong>Refer\u00eancias<\/strong><\/p>\n\n<p>1. Gabinete Federal de Sa\u00fade P\u00fablica FOPH, Coordena\u00e7\u00e3o do fornecimento de medicamentos essenciais para a Covid-19, <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html,<\/a> \u00faltimo acesso: 20.02.2023<em>.<\/em><br\/>2\u00aa Sociedade Su\u00ed\u00e7a de Infeciologia (SSI). Recommendations on the early use of covid-19 therapies and prophylaxis prepared by the Swiss Society for Infectious<em> Diseases<\/em> (SSI), 06 de fevereiro de 2023 <a href=\"https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.bag.admin.ch\/bag\/de\/home\/krankheiten\/ausbrueche-epidemien-pandemien\/aktuelle-ausbrueche-epidemien\/novel-cov\/information-fuer-die-aerzteschaft\/covid19_vo_2.html,<\/a> \u00faltimo acesso em 20.02.2023.<br\/>3. PAXLOVID\u00ae (nirmatrelvir [PF-07321332] e ritonavir): informa\u00e7\u00f5es actuais sobre o produto em <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch.<\/a><br\/>4. Lista dos medicamentos autorizados na Su\u00ed\u00e7a <a href=\"https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/listen_neu.html\" target=\"_blank\" rel=\"noopener\">https:\/\/www.swissmedic.ch\/swissmedic\/de\/home\/services\/listen_neu.html,<\/a> \u00faltimo acesso: 20.02.2023.<br\/>5. COVID-19 Drug Interactions, <a href=\"https:\/\/www.covid19-druginteractions.org\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.covid19-druginteractions.org\/,<\/a> \u00faltimo acesso: 26.04.2023<em>.<\/em><\/p>\n\n<p>As refer\u00eancias est\u00e3o dispon\u00edveis mediante pedido. <\/p>\n\n<p><a href=\"https:\/\/medizinonline.com\/pt-pt\/breve-informacao-tematica\/\" target=\"_blank\" rel=\"noreferrer noopener\">Breve informa\u00e7\u00e3o t\u00e9cnica sobre PAXLOVID\u00ae  <\/a><\/p>\n\n<p>Pode encontrar as informa\u00e7\u00f5es t\u00e9cnicas actuais sobre PAXLOVID\u00ae em <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch.<\/a><\/p>\n\n<p>Este medicamento est\u00e1 sujeito a um controlo adicional. Para mais informa\u00e7\u00f5es, consulte o folheto informativo para especialistas\/doentes de PAXLOVID\u00ae em <a href=\"https:\/\/www.swissmedicinfo.ch\/ShowText.aspx?textType=FI&amp;lang=DE&amp;authNr=68793\" target=\"_blank\" rel=\"noreferrer noopener\">www.swissmedicinfo.ch.<\/a><\/p>\n\n<p>Respons\u00e1vel pelo conte\u00fado e financiado por: Pfizer AG, Sch\u00e4renmoosstrasse 99, 8052 Zurique  <\/p>\n\n<p>PP-PAX-CHE-0240 abril de 2023<\/p>\n\n<p>Contribui\u00e7\u00e3o em linha desde 19.09.2023<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Os medicamentos antivirais podem ser utilizados em doentes com COVID-19 com risco acrescido de progress\u00e3o grave da doen\u00e7a.1, 2 O antiv\u00edrico PAXLOVID\u00ae (nirmatrelvir [PF-07321332] \/ ritonavir) \u00e9 o \u00fanico tratamento&hellip;<\/p>\n","protected":false},"author":14,"featured_media":360179,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Webcast Dr. Braun e Prof. Marzolini","footnotes":""},"category":[11339,11421,11551],"tags":[69125],"powerkit_post_featured":[],"class_list":["post-360170","post","type-post","status-publish","format-standard","has-post-thumbnail","category-conteudo-do-parceiro","category-infecciologia","category-rx-pt","tag-webcast-pt-pt","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-27 21:24:18","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":360169,"slug":"covid-19-en-la-practica-diaria-la-opcion-de-tratamiento-con-paxlovid","post_title":"COVID-19 en la pr\u00e1ctica diaria: la opci\u00f3n de tratamiento con PAXLOVID","href":"https:\/\/medizinonline.com\/es\/covid-19-en-la-practica-diaria-la-opcion-de-tratamiento-con-paxlovid\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/360170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=360170"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/360170\/revisions"}],"predecessor-version":[{"id":360182,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/360170\/revisions\/360182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/360179"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=360170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=360170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=360170"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=360170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}